Get the Stockscreener App
70.35
2.26%
-1.63
After Hours:
70.25
-0.10
-0.14%
Tempus Ai Inc stock is traded at $70.35, with a volume of 8.98M.
It is down -2.26% in the last 24 hours and up +8.87% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$71.98
Open:
$70.1
24h Volume:
8.98M
Relative Volume:
1.40
Market Cap:
$12.77B
Revenue:
$1.36B
Net Income/Loss:
$-302.91M
P/E Ratio:
-40.94
EPS:
-1.7182
Net Cash Flow:
$-219.93M
1W Performance:
-14.10%
1M Performance:
+8.87%
6M Performance:
+50.27%
1Y Performance:
-24.36%
1-Day Range:
$68.66
$73.09
1-Week Range:
$68.66
$87.99
52-Week Range:
$40.77
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, TXG, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
70.35 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
282.50 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
63.80 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
76.10 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
97.86 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Tempus AI (NASDAQ:TEM) Shares Down 6.1%Here's Why - MarketBeat
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026 - Business Wire
What Does Today’s Signal Mean for Tempus AI (NASDAQ:TEM)? - Kalkine Media
$Tempus AI (TEM.US)$ - Moomoo
A trading plan governed the sale of 10,281 Tempus AI (TEM) shares by its diagnostics CEO at $85 each. - Stock Titan
Tempus AI, Inc. Class A Bonds — Corporate Bond Rates - TradingView
Why Tempus AI (TEM) Stock Is Down Today - Quiver Quantitative
Best Artificial Intelligence Stocks To ConsiderSeptember 29th - MarketBeat
Current ratio of Tempus AI, Inc. Class A – HAN:F3M - TradingView
Tempus AI Has Three FDA-Cleared ECG Algorithms - FourWeekMBA
Tempus AI receives FDA clearance for heart valve AI tool - Investing.com
Tempus AI receives FDA clearance for heart valve AI tool By Investing.com - Investing.com India
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation - Business Wire
Cathie Wood's Ark Invest weekly recap: boosts Meta, Rocket Lab; cuts Tempus AI, CrowdStrike (ARKK:BATS) - Seeking Alpha
Tempus AI CEO Ryan Fukushima sells $49,000 in stock By Investing.com - Investing.com South Africa
Tempus AI CEO Lefkofsky sells $16.1m common stock By Investing.com - Investing.com South Africa
Tempus AI CEO Lefkofsky sells $16.1m common stock - Investing.com
Tempus AI CEO Ryan Fukushima sells $49,000 in stock - Investing.com
Tempus AI CAO Ryan Bartolucci sells $529,650 in stock - Investing.com
Form 4 Tempus AI Inc For: 27 September By Investing.com - Investing.com Canada
Tempus AI EVP Andrew Polovin sells 2,951 shares for $221,325 - Investing.com
Form 144 Tempus AI For: 27 September - Investing.com India
Artificial Intelligence Stocks To Watch TodaySeptember 26th - MarketBeat
Tempus AI gets FDA clearance for pulmonary hypertension AI tool - scanx.trade
Tempus AI, Inc. Class A Ignites Investor Hype - TipRanks
Form 144 Tempus AI For: 26 September - Investing.com India
Form 144 Tempus AI For: 26 September By Investing.com - Investing.com Australia
Artificial Intelligence Stocks To Follow TodaySeptember 25th - MarketBeat
Tempus AI, Inc. (TEM) options chain - Yahoo Finance Australia
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Leica Biosystems brings Tempus pathology products to Aperio AI Store, accelerating AI-powered capabilities for oncology research - News-Medical
AI in Clinical Trials Market Set for Transformative Growth Through 2040, Unlocking Opportunities Across Trial Phases, Therapeutic Areas, End Users and Key Global Regions - GlobeNewswire Inc.
#Day 10Looking to Take Profit on my tempus - Moomoo
Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Company Stock - MarketBeat
RXRX Stock Rises As Tempus AI Deal Resets Growth Story - StocksToTrade
Tempus AI(TEM.US) 10% Shareholder Sells US$19.37 Million in Common Stock - moomoo.com
Tempus AI CEO-linked entities sell 250,000 shares - Stock Titan
Tempus AI Inc Stock (TEM) Closed Up by 7.38% on Sep 24: What Investors Need To Know - TradingKey
Tempus AI (NASDAQ:TEM) Trading 6.1% HigherTime to Buy? - MarketBeat
Tempus AI Soars As Wall Street Bets On Data - TipRanks
Promising Artificial Intelligence Stocks To ConsiderSeptember 24th - MarketBeat
Tempus AI Chief Accounting Officer Sells $529,650 of Stock - The Globe and Mail
Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4 - finance.yahoo.com
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics By Investing.com - Investing.com South Africa
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics - Investing.com
Tempus AI (TEM) Has a $75 Goldman Sachs Target, But Its Data Business Faces a Bigger Test - Yahoo Finance
Tempus AI Stock Price: TEM Stock Chart, Market Cap & News Today - CoinGecko
Tempus AI (NASDAQ:TEM) Upgraded by The Goldman Sachs Group to Hold Rating - MarketBeat
Tempus AI: High Risk, But With A Great Cause (NASDAQ:TEM) - Seeking Alpha
Goldman Sachs initiates coverage of Tempus AI (TEM.US) with a Neutral rating: Diagnostic business to benefit from reimbursement tailwinds, while data contracts enter a "validation phase" - moomoo.com
Tempus AI: Data And Applications Will Unlock More Upside (NASDAQ:TEM) - Seeking Alpha
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
5.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):